首页 | 本学科首页   官方微博 | 高级检索  
     

门冬胰岛素30治疗2型糖尿病疗效观察
引用本文:孙伟,朱江,徐勉. 门冬胰岛素30治疗2型糖尿病疗效观察[J]. 蚌埠医学院学报, 2010, 35(1): 35-36. DOI: 10.3969/j.issn.1000-2200.2010.01.013
作者姓名:孙伟  朱江  徐勉
作者单位:1. 安徽省淮北市人民医院内分泌科, 235000;2. 昆明医学院附属第二医院内分泌科, 云南昆明 650032
摘    要:目的:观察胰岛素类似物门冬胰岛素30治疗血糖控制较差的2型糖尿病患者的临床疗效、安全性及耐受性。方法:将40例2型糖尿病患者随机分为两组,B组于早、晚餐前30 min注射预混人胰岛素30R,A组于早、晚餐时注射门冬胰岛素30,药物剂量根据血糖高低调整,比较治疗后两组空腹血糖、餐后血糖、血糖达标时间、胰岛素用量、发生低血糖时血糖值。结果:门冬胰岛素30和预混人胰岛素30R两组均可有效降低血糖(P<0.01),降糖效果差异无统计学意义(P>0.05),门冬胰岛素30组发生低血糖时血糖值高于预混人胰岛素30R组(P<0.05),尤其是夜间严重低血糖水平的发生。结论:在2型糖尿病患者中应用门冬胰岛素30降糖效果显著,安全性高,患者耐受性和依从性好。

关 键 词:糖尿病  2型   门冬胰岛素30   预混人胰岛素30R
收稿时间:2008-09-16

Clinical study on insulin analogue aspart 30 in the treatment of type 2 diabetes mellitus
SUN Wei,ZHU Jiang,XU Mian. Clinical study on insulin analogue aspart 30 in the treatment of type 2 diabetes mellitus[J]. Journal of Bengbu Medical College, 2010, 35(1): 35-36. DOI: 10.3969/j.issn.1000-2200.2010.01.013
Authors:SUN Wei  ZHU Jiang  XU Mian
Affiliation:1. Department of Endocrinology, Huaibei People′s Hospital, Huaibei Anhui 235000;2. Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical College, Kunming Yunnan 650032, China
Abstract:Objective:To observe the clinical therapeutic effects,safety and resistance of insulin analogue aspart 30 in treatment for type 2 diabetes mellitus.Methods:Forty patients with type 2 diabetes mellitus.were randomly divided into A group and B group,aspart 30 was used in A group patients while novolin 30R was used in B group patients,A group and B group patients were treated twice daily in morning and evening respectively.And the drug doses were adjusted momentarily according to the concentration of blood glu...
Keywords:diabetes mellitus  type 2  aspart 30  novolin 30R  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号